Back to search

Pharmacokinetics of molsidomine and of its active metabolite, SIN‐1 (or linsidomine), in the elderly

Data up to Jan 2025

Published1991
Citations2
References28

Total Citations Per Year

Abstract

References (28)

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1976 • 1,111 citations

The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

1975 • 693 citations

Drug Disposition in Old Age

1982 • 589 citations

Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking

1975 • 320 citations

The effect of ageing on the hepatic clearance of propranolol.

1979 • 241 citations

Clinical Pharmacokinetic Considerations in the Elderly

1989 • 178 citations

Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium)

1978 • 165 citations

Clinical Pharmacokinetic Considerations in the Elderly

1997 • 136 citations

Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination

1979 • 122 citations

Functional Defects in the Aging Kidney

1972 • 121 citations

Diazepam Kinetics in Relation to Age and Sex

1981 • 109 citations

Absorption and Disposition of Chlordiazepoxide in Young and Elderly Male Volunteers

1977 • 108 citations

Molsidomine in the Treatment of Patients with Angina Pectoris

1980 • 102 citations

Reduced quinidine clearance in elderly persons

1978 • 88 citations

The Effect of Age on the Pharmacokinetics of Diazepam

1980 • 71 citations

Molecular Aspects Underlying the Vasodilator Action of Molsidomine

1989 • 63 citations

Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man

1988 • 50 citations

Molecular Aspects Underlying the Vasodilator Action of Molsidomine

1989 • 37 citations

Haemodynamic effects of molsidomin

1978 • 34 citations

Acute double blind trial of a new anti-anginal drug: Molsidomine

1978 • 32 citations

Prevalence of high (3s)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age

1980 • 27 citations

Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris

1981 • 26 citations

Phenazone (antipyrine) metabolism and distribution in young and elderly adults

1975 • 25 citations

Relaxations to SIN-1, Nitric Oxide, and Sodium Nitroprusside in Canine Arteries and Veins

1989 • 14 citations

Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study

1984 • 10 citations

Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatography

1990 • 9 citations

[Human pharmacokinetics of molsidomine].

1983 • 7 citations

Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.

1991 • 7 citations

Cited By (0)

Loading...
Pharmacokinetics of molsidomine and of its active metabolite, SIN‐1 (or linsidomine), in… (1991) – Fundamental and Clinical Pharmacology | Metascience Observatory Explorer